Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?

Conventional transarterial chemoembolization (c-TACE) was validated in 2002 for intermediate stage hepatocellular carcinoma (HCC). Recent improvements in overall survival after c-TACE in HCC is linked to both better patient selection, and improvement in treatment technologies: catheter, image guidan...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hepat Oncol
Main Authors: de Baere, Thierry, Tselikas, Lambros, Deschamps, Frederic, Boige, Valerie, Ducreux, Michel, Hollebecque, Antoine
Format: Artigo
Jezik:Inglês
Izdano: Future Medicine Ltd 2016
Teme:
Special Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6095432/
https://ncbi.nlm.nih.gov/pubmed/30191032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2015-0001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki